Clinical Trials Browser

Phase 2 × OTHER × relmacabtagene autoleucel × Clear all

NCT07326371 2026-01-08

Glofitamab Combined With CAR-T Therapy in R/R DLBCL

Phase 2 Not yet recruiting

Dendritic Cell Sarcoma, Interdigitating

NCT05590221 2024-01-08

Relmacabtagene Autoleucel as First-Line Therapy for High-Risk Large B-Cell Lymphoma

Phase 2 Unknown

Lymphoma, B-Cell